Western Europe continues to be one of the largest pharmaceutical markets in the world. With greatly developed healthcare and medical systems, highly trained Investigators and standardization across multiple countries, in the form of the European Clinical Trials Directive, Western Europe remains an important region for clinical research.
With our global headquarters in the UK, orphan reach is highly experienced in conducting studies across Western Europe. In particular, with Oncology a major focus area for many Western European countries, orphan reach has conducted numerous studies in this field.
To successfully deliver a European project, you need a CRO that understands first-hand the different socio-economic environments across the multiple countries, you need a CRO with strong foundations in Europe, you need orphan reach.
Central and Eastern Europe
Biopharmaceutical sponsors continue to realise the importance of the inclusion of Central Eastern Europe, as an emerging region, in their study country mix. This is supported by:
orphan reach is an expert in conducting clinical research across the whole of Central Eastern Europe. We have a vast team spanning the region with highly experienced Clinical Research Associates (in many cases medically qualified) locally on the ground in each country. We have experience and coverage in the following countries:
If you want fast approval, rapid recruitment, high quality data and lower costs then orphan reach can deliver the solution in Central Eastern Europe.